YOKNEAM, Israel, July 25,
2023 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD)
("InMode"), a leading global provider of innovative medical
technologies, is pleased to announce the completion of a
significant intellectual property (IP) transaction in the women's
health and wellness market.
InMode has acquired all the intellectual property assets of
Viveve Medical Inc. Viveve is a medical technology company focused
on women's wellness and the treatment of female stress urinary
incontinence (SUI). All of Viveve's worldwide patents will be
transferred and registered under InMode Ltd.
The acquisition of Viveve's patent portfolio, in addition to an
exclusive licensing agreement previously signed with the
University of California relating to a
bladder denervation patent, coupled with InMode's existing robust
patent portfolio, fortifies InMode as the global market leader in
women's wellness products development.
"Development of products for Women's Wellness continues to be a
strategic pillar of our long-term growth strategy. By investing in
new patents and licensing rights, InMode is not only strengthening
its intellectual property portfolio but is also reaffirming its
commitment to commercializing innovative technologies. InMode
protects its IP worldwide against any company that attempts to
infringe its proprietary rights," said Moshe Mizrahy, InMode CEO.
About InMode
InMode is a leading global provider
of innovative medical technologies. InMode develops,
manufactures, and markets devices harnessing novel radiofrequency
("RF") technology. InMode strives to enable new emerging surgical
procedures as well as improve existing treatments. InMode has
leveraged its medically-accepted minimally-invasive RF technologies
to offer a comprehensive line of products across several categories
for plastic surgery, gynecology, dermatology, otolaryngology, and
ophthalmology. For more information about InMode and its wide
array of medical technologies, visit www.inmodemd.com.
Logo -
https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg
Press Contact:
Behrman Communications
Amanda Reinstein
areinstein@behrmanpr.com
Investor Contact:
MS-IR LLC
Miri Segal – Scharia
ir@inmodemd.com
Tel: 917-607-8654
View original
content:https://www.prnewswire.com/news-releases/inmode-expands-womens-health-and-wellness-market-footprint-through-acquisition-of-viveve-patents-301884093.html
SOURCE InMode Ltd.
